Ruiz García, AntonioArranz Martínez, EzequielMorón Merchante, IgnacioPascual Fuster, VicenteTamarit, Juan J.Trias Villagut, FerránPinto Sala, XavierAscaso, Juan F.Grupo de Diabetes de la Sociedad Española de Arteriosclerosis2021-06-152021-06-152018Ruiz-García, A., Arranz-Martínez, E., Morón-Merchante, I., Pascual-Fuster, V., Tamarit, J. J., Trias-Villagut, F., Pintó-Sala, X., Ascaso, J. F., & Grupo de Diabetes de la Sociedad Española de Arteriosclerosis. (2018). Consensus document of the Spanish Society of Arteriosclerosis (SEA) for the prevention and treatment of cardiovascular disease in type 2 diabetes mellitus. Clínica e Investigación en Arteriosclerosis, 30(S1), 1–19. https://doi.org/10.1016/j.arteri.2018.06.0060214-91681578-1879http://hdl.handle.net/11268/10148A consensus document of the Diabetes working group of the Spanish Society of Arteriosclerosis (SEA) is presented, based on the latest studies and conceptual changes that have appeared. It presents the cardiovascular risk in type 2 diabetes mellitus (T2DM) and the action guidelines for the prevention and treatment of cardiovascular disease (CVD) associated with T2DM. The importance of lipid control, based on the objective of LDL-C and non-HDL-C when there is hypertriglyceridemia, and the blood pressure control in the prevention and treatment of CVD is evaluated. The new hypoglycemic drugs and their effects on CVD are reviewed, as well as the treatment and control guidelines of hyperglycemia. Likewise, the use of antiplatelet agents is considered. Emphasis is placed on the importance of global and simultaneous action on all risk factors to achieve a significant reduction in cardiovascular events.engDiabetes mellitus tipo 2Inhibidores de agregación plaquetariajournal article10.1016/j.arteri.2018.06.006restricted accessEnfermedad cardiovascularTratamiento médicoFarmacología